…
Epiminder Limited engages in the development and manufacture of monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. The company offers Minder system, an electroencephalographic (EEG) recording and transmitting device implanted under the scalp. Its Minder system comprises Minder Implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder Wearable, which receives and stores EEG recordings wirelessly transmitted from the Minder implant to the Minder app; Minder App that collects and transmits EEG data from the Minder implant via Bluetooth and uploads to the Minder Cloud for processing; and Minder Cloud, a secure, online portal which allows healthcare professionals to download patient data. The company was incorporated in 2017 and is based in Melbourne, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Epiminder Ltd is an Australian Securities Exchange-listed company for which public disclosures provide limited detail about its core operations and commercial strategy. Because material growth drivers are not clearly documented, investors should monitor corporate filings, product development announcements and cash position to assess whether the company appears positioned to develop a credible pathway to revenue or asset monetization.
The principal investment risk is the lack of transparent operational and financial information combined with small-cap liquidity and financing risk that may impede execution and value realization.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
| Income before tax | -42.73M | -34.51M | -22.39M | -21.34M |
| Net income | -42.73M | -34.51M | -22.39M | -21.34M |
| Selling general administrative | 16.12M | 8.93M | 5.99M | 6.11M |
| Gross profit | -4.00M | - | - | - |
| Reconciled depreciation | 0.04M | 0.07M | 0.09M | 0.08M |
| Operating income | -43.65M | -28.59M | -21.08M | -20.64M |
| Interest expense | 1.22M | 3.04M | 1.95M | 1.01M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M |
| Net interest income | 0.91M | -3.04M | -1.95M | -1.01M |
| Cost of revenue | 4.00M | - | - | - |
| Total other income expense net | - | -2.88M | 0.64M | 0.31M |
| Net income from continuing ops | -42.73M | -34.51M | -22.39M | -21.34M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
| Total assets | 90.84M | 130.71M | 0.00M | 0.00M |
| Intangible assets | 13.15M | 13.15M | - | - |
| Other current assets | 0.75M | 0.15M | - | - |
| Total liab | 9.17M | 23.32M | 0.00M | 0.00M |
| Total stockholder equity | 81.67M | 107.39M | 0.00M | 0.00M |
| Capital stock | 208.57M | 207.78M | - | - |
| Retained earnings | -140.99M | -110.73M | - | - |
| Cash | 75.79M | 116.95M | - | 0.00M |
| Total current liabilities | 7.97M | 23.21M | 0.00M | 0.00M |
| Total current assets | 77.60M | 117.49M | 0.00M | 0.00M |
| Net receivables | - | 0.38M | - | - |
| Accounts payable | 1.85M | 22.64M | - | - |
| Non current assets total | 13.23M | 13.22M | 0.00M | 0.00M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
| Net borrowings | 0.50M | 14.58M | 8.44M | 7.56M |
| Total cash from financing activities | 109.99M | 14.58M | 13.98M | 10.38M |
| Net income | -42.73M | -34.51M | -22.39M | -21.34M |
| Change in cash | 66.68M | -2.44M | 0.16M | -3.90M |
| Begin period cash flow | 8.85M | 11.31M | 11.17M | 15.09M |
| End period cash flow | 75.79M | 8.85M | 11.31M | 11.17M |
| Issuance of capital stock | 125.00M | - | 5.54M | 2.82M |
| Sale purchase of stock | -9.56M | - | - | - |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| EPI Epiminder Ltd |
-0.01 3.57% |
0.27 | - | - | 24.39 | 0.69 |
| COH Cochlear Ltd |
2.26 1.50% |
152.98 | 68.64 | 27.40 | 4.30 | 5.34 |
| IMR Imricor Medical Systems Inc |
0.06 4.72% |
1.33 | - | - | 36401.21 | 17.45 |
| AVR Anteris Technologies Global Corp |
0.50 5.88% |
9.00 | - | - | 356.02 | 2.19 |
| AVH Avita Medical Inc |
-0.11 2.13% |
5.06 | - | 9.97 | 9.59 | 7.17 |
Epiminder Limited engages in the development and manufacture of monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. The company offers Minder system, an electroencephalographic (EEG) recording and transmitting device implanted under the scalp. Its Minder system comprises Minder Implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder Wearable, which receives and stores EEG recordings wirelessly transmitted from the Minder implant to the Minder app; Minder App that collects and transmits EEG data from the Minder implant via Bluetooth and uploads to the Minder Cloud for processing; and Minder Cloud, a secure, online portal which allows healthcare professionals to download patient data. The company was incorporated in 2017 and is based in Melbourne, Australia.
| Name | Title | Year Born |
|---|---|---|
| Dr. Rohan J. Hoare Ph.D. | CEO, MD & Director | 1964 |
| Prof. Mark Cook A.O. | Founder & Chief Medical Officer | NA |
| Mr. Mark McLellan | CFO & Company Secretary | NA |
| Dr. John Heasman | Chief Operating Officer | NA |
| Mr. Toby McSweeney | CTO & VP of Quality | NA |
| Ms. Karen Campitelli | Company Secretary | NA |
| Ms. Belinda Ann Cleminson BEd, GIA (Cert) | Joint Company Secretary | NA |
| Mr. Toby McSweeney | Chief Technology Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.